高血压防治药物治疗与监管建议

来源 :上海食品药品监管情报研究 | 被引量 : 0次 | 上传用户:red0035
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
由卫生部疾病预防控制局、国家心血管病中心等制定的2009年基层版《中国高血压防治指南》是我国第一部面向基层的实用性高血压防治指南。本研究针对2009年基层版《中国高血压防治指南》的特点,和涉及到的社会热点问题及其实际意义加以讨论和剖析,为高血压防治工作者和高血压防治药物监管工作者提供合理化建议。 The 2009 edition of “Guidelines for the Prevention and Treatment of Hypertension in China”, which was formulated by the Bureau of Disease Prevention and Control of the Ministry of Health and the National Cardiovascular Center, was the first practical guideline for prevention and treatment of hypertension in our country. In this study, we discussed and analyzed the characteristics of the guideline on prevention and treatment of hypertension in China in 2009 and the social hot issues involved and its practical significance, and provided reasonable suggestions for hypertension prevention and treatment workers and hypertension supervisory workers .
其他文献